We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Sentinel Diagnostics

Sentinel Diagnostics develops and manufactures in-vitro diagnostic medical devices for routine analysis and specific ... read more Featured Products: More products

Download Mobile App





Sentinel Diagnostics Presents Latest Breakthroughs in Diagnostics

By LabMedica International staff writers
Posted on 12 Nov 2024

Sentinel Diagnostics (Milano, Italy) is sharing its latest breakthroughs in medical diagnostics at MEDICA 2024. More...

The company is also hosting exciting presentations on molecular diagnostics, fecal immunochemical testing (FIT), chromatography, and lateral flow tests.

At this year’s MEDICA, Sentinel is showcasing is wide portfolio of compatible freeze-dried kits based on its proprietary STAT-NAT (Stabilized Amplification Technology) technology that has been developed with a new protective compound able to stabilize the activity of enzymes for a very long time with no temperature-controlled storage requirements. STAT-NAT technology yields very good performances in all the most diffused molecular biology techniques. It can improve test sensitivity even with low-concentrated DNA samples and contains all the reaction components. Sentinel is also highlighting its lyophilized STAT-NAT kits for various application areas such as virology, healthcare-associated infections, parasitology, and respiratory infections.

Designed to work with the lyophilized kits is Sentinel’s SENTiNAT 200 molecular diagnostics system that contains everything needed to perform a complete PCR analysis- rom sample extraction to Real-Time PCR results interpretation. The fully automated multiparametric system for pathogens detection can perform a multiparametric analysis on different matrices from one or more patients, using the same extraction and amplification protocol. Smart software takes care of every step of the process from sample loading to the result analysis with visual and simple terms to avoid any human errors.

At MEDICA 2024, Sentinel is also highlighting FOBGold line, its complete line for fecal occult blood testing (FIT). This includes the SENTiFIT 270 high-speed FIT system with a throughput of up to 270 tests per hour and featuring a patented pierceable tube for high-volume CRC screening. Also being showcased is the SENTiFOB automated FIT system with a throughput of up to tests per and compatible with pierceable tubes. In addition, Sentinel is highlighting the CALiaGold quantitative latex immunoassay for fecal calprotectin measurement as a marker of intestinal inflammation. The CALiaGold solution, together with the SENTiFIT 270 and SENTiFOB automated analyzers, offers a specific diagnostic system to differentiate IBD (Inflammatory Bowel Disease) from IBS (Irritable Bowel Syndrome). Visitors to the Sentinel booth can also learn more about the FOB Gold system which comprises a unique “2 in 1” tube for sample collection and a new generation immunological latex reagent for the determination of FOB.

Related Links:
Sentinel Diagnostics 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Pipette Calibration System
Artel PCS®
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.